Bailard’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.04M | Sell |
57,700
-7
| -0% | -$611 | 0.12% | 143 |
|
|
2025
Q1 | $3.94M | Sell |
57,707
-756
| -1% | -$51.6K | 0.1% | 154 |
|
|
2024
Q4 | $4.55M | Buy |
58,463
+16,968
| +41% | +$1.32M | 0.12% | 145 |
|
|
2024
Q3 | $2.78M | Sell |
41,495
-15,549
| -27% | -$1.04M | 0.07% | 196 |
|
|
2024
Q2 | $6.47M | Sell |
57,044
-4,980
| -8% | -$565K | 0.18% | 117 |
|
|
2024
Q1 | $8.6M | Buy |
62,024
+6,356
| +11% | +$882K | 0.24% | 94 |
|
|
2023
Q4 | $6.91M | Sell |
55,668
-9,850
| -15% | -$1.22M | 0.2% | 110 |
|
|
2023
Q3 | $6.11M | Buy |
65,518
+14,950
| +30% | +$1.39M | 0.2% | 106 |
|
|
2023
Q2 | $6.5M | Buy |
50,568
+8,937
| +21% | +$1.15M | 0.23% | 97 |
|
|
2023
Q1 | $4.84M | Buy |
41,631
+6,023
| +17% | +$700K | 0.17% | 114 |
|
|
2022
Q4 | $4.03M | Sell |
35,608
-88
| -0.2% | -$9.97K | 0.15% | 123 |
|
|
2022
Q3 | $2.88M | Sell |
35,696
-1,064
| -3% | -$85.7K | 0.12% | 149 |
|
|
2022
Q2 | $2.74M | Sell |
36,760
-736
| -2% | -$54.9K | 0.11% | 165 |
|
|
2022
Q1 | $4.8M | Sell |
37,496
-12
| -0% | -$1.54K | 0.16% | 123 |
|
|
2021
Q4 | $5.04M | Buy |
37,508
+220
| +0.6% | +$29.5K | 0.16% | 121 |
|
|
2021
Q3 | $5.1M | Hold |
37,288
| – | – | 0.17% | 116 |
|
|
2021
Q2 | $3.98M | Hold |
37,288
| – | – | 0.14% | 143 |
|
|
2021
Q1 | $3.35M | Buy |
+37,288
| New | +$3.35M | 0.12% | 148 |
|